{"filing":{"accession_number":"0001193125-26-253604","cik":"0001994702","ticker":"KYTX","company_name":"Kyverna Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-02","report_date":null,"primary_document":"kytx-20260527.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1994702/000119312526253604/kytx-20260527.htm"},"events":[{"id":7478,"run_id":6571,"accession_number":"0001193125-26-253604","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder voting results from Kyverna's 2026 Annual Meeting of Stockholders held on May 27, 2026. The filing reports the voting outcomes for two proposals: election of two Class II directors (Ian Clark and Christi Shaw) and ratification of BDO USA, P.C. as the independent auditor. The detailed vote tallies (votes for, against, withheld, and broker non-votes) are characteristic of Item 5.07 shareholder vote results disclosures, which are material to investors as they confirm the composition of the board and auditor appointment.","company_name":"Kyverna Therapeutics, Inc.","ticker":"KYTX","filing_date":"2026-06-02","form":"8-K","submitted_at":null,"items":[{"id":3594,"accession_number":"0001193125-26-253604","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Kyverna's 2026 Annual Meeting of Stockholders held on May 27, 2026. The filing reports the voting outcomes for two proposals: election of two Class II directors (Ian Clark and Christi Shaw) and ratification of BDO USA, P.C. as the independent auditor. The detailed vote tallies (votes for, against, withheld, and broker non-votes) are characteristic of Item 5.07 shareholder vote results disclosures, which are material to investors as they confirm the composition of the board and auditor appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:18:44.046417+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":3594,"accession_number":"0001193125-26-253604","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Kyverna's 2026 Annual Meeting of Stockholders held on May 27, 2026. The filing reports the voting outcomes for two proposals: election of two Class II directors (Ian Clark and Christi Shaw) and ratification of BDO USA, P.C. as the independent auditor. The detailed vote tallies (votes for, against, withheld, and broker non-votes) are characteristic of Item 5.07 shareholder vote results disclosures, which are material to investors as they confirm the composition of the board and auditor appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:18:44.046417+00:00","company_name":"Kyverna Therapeutics, Inc.","ticker":"KYTX","filing_date":"2026-06-02"}]}